Loading...
The efficacy and safety of ALK inhibitors in the treatment of ALK‐positive non‐small cell lung cancer: A network meta‐analysis
PURPOSE: The current study was carried out to compare the effectiveness and safety of different ALK inhibitors in treating ALK+ NSCLC. METHODS: Progression‐free survival (PFS), disease control rate (DCR), overall response rate (ORR), and intracranial ORR and DCR have been aggregated to appraise the...
Saved in:
| Published in: | Cancer Med |
|---|---|
| Main Authors: | , , , , |
| Format: | Artigo |
| Language: | Inglês |
| Published: |
John Wiley and Sons Inc.
2018
|
| Subjects: | |
| Online Access: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6198244/ https://ncbi.nlm.nih.gov/pubmed/30230699 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/cam4.1768 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|